ENZOKAST–AB Tablets

ENZOKAST–AB Tablets (Acebrophylline Sustained Release & Montelukast) – Advanced Control for Asthma & Allergic Bronchitis

ENZOKAST–AB Tablets combine Acebrophylline (Sustained Release) and Montelukast to provide comprehensive respiratory support in asthma, allergic bronchitis, and chronic obstructive airway conditions. This dual-action formulation targets both bronchospasm and airway inflammation for improved breathing and long-term control.

Acebrophylline is a bronchodilator and mucoregulator that relaxes bronchial smooth muscles, reduces airway obstruction, and facilitates easier mucus clearance. Its sustained release formulation ensures prolonged therapeutic action and improved patient compliance.
Montelukast is a leukotriene receptor antagonist that reduces airway inflammation, prevents bronchoconstriction, and helps control allergy-related respiratory symptoms.

Key Benefits:

• Relieves bronchospasm and improves airflow

• Reduces airway inflammation and hypersensitivity

• Facilitates mucus clearance

• Controls allergic respiratory symptoms

• Sustained release formula for prolonged effect

• Suitable for long-term management of asthma and COPD

Composition:

Acebrophylline (Sustained Release)
Montelukast

Dosage Form: Tablets
Category: Bronchodilator & Leukotriene Receptor Antagonist Combination
Indication: Bronchial asthma, allergic bronchitis, COPD, wheezing, and airway inflammation